Search results

Narrow your search

Result types
Article type
Jurisdiction
Practice area

Showing 1171 - 1180 of 1183 for "United States" with applied filters

News & Analysis

Canada’s response to COVID-19: Regulatory changes and guidance

24 April 2020 by LMG Life Sciences

Smart & Biggar attorneys detail flexibility by Health Canada and other key developments

News & Analysis

2020 research cycle for US and Canada has officially launched!

25 March 2020 by LMG Life Sciences

Now accepting submissions for firm rankings and awards

News & Analysis

Key 2020 research dates announced for US and Canada

04 March 2020 by LMG Life Sciences

Submission process will begin on March 25

News & Analysis

2019 firm and individual rankings are now live

25 September 2019 by LMG Life Sciences

New content includes national firm rankings, life sciences stars and editorial reviews

News & Analysis

2019 LMG Life Sciences research has officially begun!

22 March 2019 by LMG Life Sciences

Now accepting firm surveys and partner interviews

News & Analysis

Research begins for LMG Life Sciences 2018

12 April 2018 by LMG Life Sciences

Legal Media Group has officially launched the 2018 LMG Life Sciences research cycle

News & Analysis

Canada in-depth introduction

29 September 2017 by Nicholas McIsaac

News & Analysis

Licensing tips from a patent litigator

06 September 2017 by LMG Life Sciences

Anyone drafting patent license agreements should follow several tips in order to avoid or better prepare for litigation later on, says Jessamyn Berniker of Williams & Connolly.

News & Analysis

Beyond Biosimilarity: Draft Guidance for Demonstrating Biological Interchangeability

06 September 2017 by LMG Life Sciences

The primary focus of the Food and Drug Administrationtion, industry and counsel preparing for the advent of follow-on biologics in the United States has been the legal and regulatory framework ...

News & Analysis

To Modify or Not to Modify, That is the Question

06 September 2017 by LMG Life Sciences

In IPRs regarding the patents to pharmaceutical compounds, patentability often turns on the obviousness of taking a known compound and modifying it based on a known technique.